中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

Influencing factors for liver inflammation grade and fibrosis degree in patients with low-level HBV DNA

DOI: 10.3969/j.issn.1001-5256.2019.05.010
Research funding:

 

  • Received Date: 2018-10-26
  • Published Date: 2019-05-20
  • Objective To investigate liver pathological features and related factors in patients with low-level HBV DNA, and to provide a basis for evaluating the conditions of such patients. Methods A total of 137 patients with an HBV DNA level of < 2000 IU/ml and > 20 IU/ml who attended The Third People's Hospital of Kunming from January 2014 to December 2017 were enrolled. Liver pathological examination was performed for all patients. Of all patients, 44 had grade 1 ( G1) liver inflammation, 84 had grade 2 ( G2) liver inflammation, and 9 had grade 3 ( G3) liver inflammation; as for fibrosis stage, 2 had S0 fibrosis, 67 had S1 fibrosis, 56 had S2 fibrosis, 9 had S3 fibrosis, and 3 had S4 fibrosis. The correlation of liver inflammation grade and fibrosis stage with age, sex, duration of HBV infection, blood biochemistry, HBsAg level, and HBV DNA was analyzed. The Kruskal-Wallis H test was used for comparison of continuous data between multiple groups, the chi-square test was used for comparison of categorical data between groups, and univariate and multivariate one-way non-conditional logistic regression analyses were used to investigate the influencing factors for ≥G2 liver inflammation and ≥S2 fibrosis. Results There were significant differences in HBsAg, platelet count ( PLT) , diameter of the splenic vein, and spleen thickness between the G1, G2, and G3 groups ( H = 7. 135, 7. 458, 7. 588, and 10. 150, all P < 0. 05) , and there were also significant differences in HBsAg, PLT, diameter of the portal vein, diameter of the splenic vein, and spleen thickness between the S0, S1, S2, S3, and S4 groups ( H = 20. 564, 12. 065, 26. 171, 14. 720, and 13. 725, all P < 0. 05) . Of all 137 patients, 44 had no or mild inflammation and necrosis ( < G2 group) and 93 had moderate or severe inflammation and necrosis ( ≥G2 group) ; age, alanine aminotransferase, alkaline phosphatase ( ALP) , white blood cell count, diameter of the splenic vein, and spleen thickness, with statistical significance determined by the univariate logistic regression analysis, were included in the multivariate analysis ( α = 0. 15) , and the results showed that age ( odds ratio [OR]= 1. 045, P < 0. 05) , ALP ( OR = 1. 019, P < 0. 05) , and spleen thickness ( OR = 1. 150, P < 0. 05) were independent risk factors for ≥G2 liver inflammation in the patients with low-level HBV DNA. Of all 137 patients, 69 had no or mild liver fibrosis ( < S2 group) and 68 had moderate or severe liver fibrosis ( ≥S2 group) ; total bilirubin, HBsAg, PLT, and diameter of the portal vein, with statistical significance determined by the univariate logistic regression analysis, were included in the multivariate analysis ( α = 0. 15) , and the results showed that HBsAg ( OR = 2. 065) , PLT ( OR = 0. 988) , and diameter of the portal vein ( OR = 2. 464) were independent risk factors for ≥S2 liver fibrosis in the patients with low-level HBV DNA. Conclusion The majority of patients with low-level HBV DNA have the indication of antiviral therapy. Age, ALP, and spleen thickness are closely associated with liver inflammation grade in patients with low-level HBV DNA, and HBsAg, PLT, and diameter of the portal vein are closely associated with liver fibrosis.

     

  • [1] CHAN HL, WONG VW, WONG GL, et al. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B[J]. Hepatology, 2010, 52 (4) :1232-1241.
    [2] THOMPSON AJ, NGUYEN T, LSER D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers:Disease phase influences correlation with viral load and intra-hepatic hepatitis B virus markers[J]. Hepatology, 2010, 51 (6) :1933-1944.
    [3] MONTAZERI G, RAHBAN M, MOHAMADNEJAD M, et al. Liver histology and HBV DN levels in chronically HBV infected patients with persistently normal alanine aminotransferase[J].Arch Iran Med, 2010, 13 (3) :193-202.
    [4] MACMAHON BJ. The natural history of chronic hepatitis B virus infection[J]. Hepatology, 2009, 49:45.
    [5] Chinese Society of Hepatology, Chinese Society of Infectious Diseases, Chinese Medcal Association. The guideline of prevention and treatment for chronic hepatitis B (2015 version) [J]. J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
    [6] TSENG TC, LIU CJ, YANG HC, et al. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads[J]. Hepatology, 2013, 57 (2) :441-450.
    [7] European Association for the Study of the Liver. EASL clinical practice guidelines:management of chronic hepatitis B virus infection[J]. Hepatel, 2012, 57 (1) :167-185.
    [8] TRAN TT. Immune tolerant hepatitis B:A clinical dilemma[J].Gastroenterol Hepal, 2011, 7 (8) :511-516.
    [9] QIU HF, LI JH, YANG WJ, et al. Analysis of related factors of ALT persistently normal patients with chronic HBV infection[J]. Chin J Nosocomiol, 2015, 25 (17) :3893-3895. (in Chinese) 邱惠芳, 李金花, 杨文君, 等.慢性乙型肝炎感染谷丙转氨酶持续正常患者肝脏病理相关因素分析[J].中华医院感染杂志, 2015, 25 (17) :3893-3895.
    [10] LI W, XU KH, ZHAO SS. Association between liver pathology and clinical features in patients with chronic HBV infection and slightly elevated alanine aminotransferase[J]. J Clin Hepatol, 2017, 33 (11) :2123-2126. (in Chinese) 李伟, 徐葵花, 赵守松. ALT轻度升高的慢性HBV感染者临床特征与病理学的关系[J].临床肝胆病杂志, 2017, 33 (11) :2123-2126.
    [11] DING HB, LI YX, LAI JQ, et al. Correlation between pathological changes of liver tissue and portal vein diameter in patients with chronic hepatitis B[J]. J Prac Hepatol, 2010, 13 (5) :369-370. (in Chinese) 丁红兵, 李奕鑫, 赖江琼, 等.慢性乙型肝炎患者肝组织病理学改变与门静脉内径的相关性分析[J].实用肝脏病杂志, 2010, 13 (5) :369-370.
    [12] HUO XP, XIE QX, JIANG XP, et al. Pathological changes of liver tissues in 486 patients with chronic hepatitis B[J]. J Prac Hepatol, 2015, 18 (4) :360-363. (in Chinese) 霍雪平, 谢琴秀, 江晓平, 等. 486例慢性乙型肝炎患者肝组织病理学变化与肝功能指标的相关性研究[J].实用肝脏病杂志, 2015, 18 (4) :360-363.
    [13] SUN HY, WANG M, LYU SJ, et al. Predictive factors of early diagnosis of liver cirrhosis in chronic HBV carriers[J/CD].Chin J Liver Dis:Electronic Edit, 2017, 9 (4) :82-85. (in Chinese) 孙海英, 王明, 吕胜军, 等.慢性HBV携带者早期肝硬化诊断的预测因素分析[J/CD].中国肝脏病杂志:电子版, 2017, 9 (4) :82-85.
    [14] HUANG CM, YANG Z, NIE YQ, et al. Value of gamma-glutamyl transpeptidase-to-platelet ratioin predicting liver fibrosis stage in chronic hepatitis B patients in Guangdong, China[J]. J Clin Hepatol, 2018, 34 (6) :1204-1208. (in Chinese) 黄春明, 杨湛, 聂玉强, 等. GGT/PLT比值对广东地区慢性乙型肝炎患者肝纤维化分期的预测价值[J].临床肝胆病杂志, 2018, 34 (6) :1204-1208.
    [15] LU HY, LIU LF, XU XY, et al. FibroScan in diagnosis of liver fibrosis in patients with different chronic liver diseases:A comparative analysis[J]. J Clin Hepatol, 2016, 32 (8) :1512-1517. (in Chinese) .陆海英, 刘玲峰, 徐小元, 等. FibroScan诊断不同类型慢性肝病肝纤维化的效果比较[J].临床肝胆病杂志, 2016, 32 (8) :1513-1517.
  • Relative Articles

    [1]Lulu ZHOU, Bing DONG, Jiejing XIN, Guanghua XU, Na LIU. Liver histopathological features of HBeAg-negative patients in the indeterminate phase of low-viral-load chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2025, 41(1): 52-56. doi: 10.12449/JCH250108
    [2]Manlei JIANG, Fei XU, Lunli ZHANG. Liver inflammation and fibrosis in HBV-infected patients with a low viral load[J]. Journal of Clinical Hepatology, 2023, 39(6): 1304-1307. doi: 10.3969/j.issn.1001-5256.2023.06.008
    [3]Huikun ZHOU, Jianning JIANG, Minghua SU, Rongming WANG, Bobin HU, Deli DENG, Huilan WEI, Xianshuai LIANG, Wenming HE, Rongsheng GUO. Efficacy of entecavir versus tenofovir disoproxil fumarate in treatment of chronic hepatitis B patients with high viral load[J]. Journal of Clinical Hepatology, 2022, 38(3): 532-536. doi: 10.3969/j.issn.1001-5256.2022.03.008
    [4]Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, Chinese Society of Perinatal Medicine, Chinese Medical Association. 2020 clinical guidelines on prevention of mother-to-child transmission of hepatitis B virus[J]. Journal of Clinical Hepatology, 2020, 36(7): 1474-1481. doi: 10.3760/cma.j.cn112141-20200213-00101
    [5]Liu Li, Liu ChunYun, Du YingRong, Huang HongLi, Chen Jie, Luo Yu, Li HuiMin, Li WeiKun, Li JunYi, Yue YunXuan. Liver inflammatory activity in chronic hepatitis B patients with a low HBV DNA level and related factors[J]. Journal of Clinical Hepatology, 2019, 35(1): 77-81. doi: 10.3969/j.issn.1001-5256.2019.01.014
    [6]Ran RuoXi, Xiao MengYao, Li AnLing, Liu SongMei. Clinical significance of the measurement of peripheral blood Epstein-Barr virus load in patients with HBV infection[J]. Journal of Clinical Hepatology, 2019, 35(4): 769-773. doi: 10.3969/j.issn.1001-5256.2019.04.013
    [7]Gu JiuLian, Liu ShouSheng, Li ChangFei, Xiao JianHan, Xin YongNing, Xuan ShiYing. Value of highly sensitive serum virological markers in hepatitis B patients with a low viral load[J]. Journal of Clinical Hepatology, 2018, 34(6): 1302-1307. doi: 10.3969/j.issn.1001-5256.2018.06.037
    [8]Qin XiaoMei, Fan ChenYing, Li ShuangJie, Peng HuiYun. Correlation of HBV DNA load with liver pathology,liver function,and serological markers of liver fibrosis in children with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(3): 472-475. doi: 10.3969/j.issn.1001-5256.2016.03.014
    [9]Li Qiang, Huang YuXian, Chen Liang. Independent predictive factors for significant liver histological changes in patients with HBe Ag-positive high-viral-load chronic HBV infection and a normal alanine aminotransferase level[J]. Journal of Clinical Hepatology, 2016, 32(7): 1310-1314. doi: 10.3969/j.issn.1001-5256.2016.07.019
    [10]Sun JianMin. Efficacy of thymosin α1 in chronic HBV infection patients with low viral load in immune-clearance or low-replication phase[J]. Journal of Clinical Hepatology, 2015, 31(2): 202-204. doi: 10.3969/j.issn.1001-5256.2015.02.014
    [11]Zhu Zhen, Cong WenMing. Clinicopathological study of intrahepatic bile duct cancers from 1982 to 2011[J]. Journal of Clinical Hepatology, 2013, 29(1): 42-44.
    [12]Liu HaiPing, Cong WenMing. Hepatocellular adenoma: new understandings of molecular pathology and novel model of clinical diagnosis and therapy[J]. Journal of Clinical Hepatology, 2013, 29(11): 801-804. doi: 10.3969/j.issn.1001-5256.2013.11.001
    [13]Gu Bin, Huang HuiQin, Hou XiaoLan, Ning Feng, Zhang Yan, Li Lu. Relationship between hepatitis C virus genotypes and viral load in Chenzhou, China[J]. Journal of Clinical Hepatology, 2013, 29(11): 832-834. doi: 10.3969/j.issn.1001-5256.2013.11.008
    [14]Zhang HengBing. Effects of marine in the treatment of chronic hepatitis B patients with low viral load[J]. Journal of Clinical Hepatology, 2012, 28(3): 176-178.
    [15]Niu ChunYan, Gao BaoHua, Zheng JianYun, Wu FangXiong, Wang Wen, Luo JianMei, Zheng NaiQing. The correlations between HBV quantity in the liver tissue and the severity of liver tissue injury in chronic hepatitis B and hepatic cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 277-279.
    [16]Yin ChiBiao, Zhang FuChun, Xian JianZhong, Cao Yang, Tang XiaoPing. Study of relationship between the serum viral load and ALT level and response to interferon therapy.[J]. Journal of Clinical Hepatology, 2004, 20(2): 97-98.
  • Cited by

    Periodical cited type(6)

    1. 李述美,刘冰,彭思璐,刘仁伟,李铃,孙宏. 慢性乙型肝炎患者HBV DNA载量及血清IL-2R、GP73、miR-21与HBVM表达模式、肝组织病理学改变的相关性. 临床和实验医学杂志. 2024(10): 1017-1021 .
    2. 沙启明. HBV-DNA载量水平与血清学标志物分组模式及前S1抗原的关系. 临床与病理杂志. 2022(01): 33-38 .
    3. 庞康清,马洪德,杨汝磊,庞国宏. 肝衰竭患者HBV-DNA载量与炎性因子及肝纤维化指标的相关性. 中国医学工程. 2022(05): 21-25 .
    4. 林宝圆,陈志鸿. 慢性乙型肝炎患者血清HBV-DNA定量检测水平与肝功能指标的关系研究. 数理医药学杂志. 2022(11): 1632-1634 .
    5. 申可,吴国标,吴彩虹,陈坚平,刘自光. 肝纤维化指标与病毒载量、病理炎症分级及纤维化分期的关系. 系统医学. 2022(21): 23-27 .
    6. 金蕾,李旭,叶珺,郜玉峰,张振华,杨凯,邹桂舟. FIB-4对HBeAg阴性慢性HBV感染者抗病毒治疗指征中肝脏炎症和纤维化的判断价值. 安徽医科大学学报. 2020(06): 960-964 .

    Other cited types(0)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-04051015202530
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 7.5 %FULLTEXT: 7.5 %META: 88.8 %META: 88.8 %PDF: 3.7 %PDF: 3.7 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 6.1 %其他: 6.1 %其他: 0.3 %其他: 0.3 %China: 0.5 %China: 0.5 %India: 0.2 %India: 0.2 %Korea Republic of: 0.5 %Korea Republic of: 0.5 %Russian Federation: 0.3 %Russian Federation: 0.3 %[]: 0.9 %[]: 0.9 %上海: 3.3 %上海: 3.3 %中卫: 0.2 %中卫: 0.2 %伊犁: 0.2 %伊犁: 0.2 %北京: 12.0 %北京: 12.0 %南京: 0.2 %南京: 0.2 %南宁: 0.3 %南宁: 0.3 %南昌: 0.8 %南昌: 0.8 %台州: 0.2 %台州: 0.2 %吉林: 0.6 %吉林: 0.6 %哥伦布: 0.2 %哥伦布: 0.2 %大连: 0.3 %大连: 0.3 %宜昌: 0.2 %宜昌: 0.2 %宿迁: 0.2 %宿迁: 0.2 %张家口: 1.4 %张家口: 1.4 %昆明: 0.8 %昆明: 0.8 %朝阳: 0.2 %朝阳: 0.2 %杭州: 0.2 %杭州: 0.2 %武汉: 0.8 %武汉: 0.8 %海口: 0.2 %海口: 0.2 %深圳: 0.2 %深圳: 0.2 %温州: 0.3 %温州: 0.3 %湖州: 0.3 %湖州: 0.3 %石家庄: 0.2 %石家庄: 0.2 %芒廷维尤: 30.5 %芒廷维尤: 30.5 %芝加哥: 0.6 %芝加哥: 0.6 %莫斯科: 1.4 %莫斯科: 1.4 %衢州: 0.2 %衢州: 0.2 %西宁: 34.4 %西宁: 34.4 %邯郸: 0.2 %邯郸: 0.2 %重庆: 0.6 %重庆: 0.6 %长春: 0.3 %长春: 0.3 %长治: 0.2 %长治: 0.2 %黔南: 0.2 %黔南: 0.2 %其他其他ChinaIndiaKorea Republic ofRussian Federation[]上海中卫伊犁北京南京南宁南昌台州吉林哥伦布大连宜昌宿迁张家口昆明朝阳杭州武汉海口深圳温州湖州石家庄芒廷维尤芝加哥莫斯科衢州西宁邯郸重庆长春长治黔南

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1787) PDF downloads(336) Cited by(6)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return